Compound ID | 1848
Class: Aminoglycoside
| Spectrum of activity: | Gram-negative |
| Details of activity: | Inhibits protein synthesis by binding to the 30S subunit of the bacterial ribosome. Active against Gram-negative bacteria |
| Description: | Semisynthetic, derived from sisomicin. Primarily used for topical application |
| Year first mentioned: | 1973 |
| Highest developmental phase: | Approved by FDA in 1983 |
| Development status: | Discontinued |
| Reason Dropped: | Withdrawn (not marketed) |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/132062458 |
| Guide to Pharmacology: | netilmicin |
| Citations: |
|